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ABSTRACT
C-mannosylation is a specific type of glycosylation in which α-mannose is covalently bound to
the C2 atom of a tryptophan via a carbon-carbon bond. Presently, it is known to occur on proteins
that contain the W-x-x-W-x-x-W/C motif found within the Thrombospondin Type-1 Repeat
(TSR), with ‘x’ denoting any amino acid. C-mannosylation has been implicated in a number of
cellular functions, including protein secretion and type I cytokine receptor function. Previous
research has shown that exogenous C-mannosylated peptides derived from TSR-containing
proteins upregulate the production of the pro-inflammatory cytokine Tumor Necrosis Factor
alpha (TNF-α) in RAW264.7 macrophage cells. This upregulation is substantially increased in
the presence of Hsc70. When these peptides are internalized by RAW264.7 cells, a binding
interaction occurs between the two proteins, which also correlates with increased TNF-α levels.
With the knowledge that exogenous C-mannosylated peptides and Hsc70 can influence cytokine
production, this study has focused on identifying endogenous C-mannosylated proteins in
RAW264.7 cells that interact with Hsc70. The potential of a naturally occurring interaction
between these two proteins could elucidate the importance of C-mannosylation in the innate
immune response. Through Hsc70 co-immunoprecipitation, a potentially C-mannosylated
protein has been identified in Junctophilin-1 (JPH1). JPH1 forms a junctional membrane
complex (JMC) between the endoplasmic reticulum and plasma membrane of excitable cells,
facilitating communication between calcium ion release channels. Tandem mass spectrometry
data suggests that the hexose appears on a single tryptophan in a peptide bearing the
sequence: E-G-E-W-A-N-N-K. This indicates that JPH1 may be an example of noncanonical C-mannosylation. To further explore the status of JPH1 as a C-mannosylated protein,
the protein was overexpressed in HEK293T cells. This experiment showed that JPH1 was not C-
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mannosylated in HEK293T cells. Noting the lack of modification, reverse transcriptase
polymerase chain reaction (RT-PCR) was performed with both RAW264.7 and HEK293T RNA.
These experiments showed that all known C-mannosyltransferase homologs (DPY19L1-4) were
expressed in HEK293T cells, while only DPY19L1 and L4 were expressed in RAW cells.
Further work is being conducted to overexpress JPH1 in RAW264.7 cells to determine why, or
if, JPH1 is C-mannosylated in this particular cell line.
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CHAPTER 1
GLYCOBIOLOGY AND THE INNATE IMMUNE RESPONSE
1.1 N- AND O-LINKED GLYCOSYLATION
Post-translational modifications compose a wide variety of reactions. As the name
suggests, these modifications occur after the translation of a nucleotide sequence into a
polypeptide. In some cases, a modification is necessary for a polypeptide to assume its final role
as an active protein in a biological setting. This study focused on glycosylation, a posttranslational modification that details the addition of a glycan (carbohydrate) to a specific amino
acid within a motif of several amino acids in a protein.
Glycosylation is an enzymatically-driven process that occurs in the endoplasmic
reticulum. One of the more thoroughly understood forms of glycosylation is known as N-linked
glycosylation. In eukaryotes, this process begins at the surface of the ER membrane with
dolichol phosphate (Dol-P), where mature N-linked glycans are built from sugar-nucleotide
donors. Multiple transferases (enzymes that attach a carbohydrate to a substrate molecule)
transfer carbohydrates from nucleotide donors such as UDP-GlcNAc and GDP-Mannose to build
a 14-sugar glycan on Dol-P, forming Glc3Man9GlcNAc2-P-P-Dol. During this process, a flippase
moves the Dol-P-P glycan from the cytosolic side of the ER to the lumen side. The enzyme
oligosaccharyltransferase takes this larger glycan and transfers it to an asparagine residue within
the N-linked glycan motif of Asn-X-Ser/Thr to proteins that translocate across the ER membrane,
providing proteins with a full length N-linked glycan that can be trimmed to serve other
functions within the cell.1 The function of these glycans is largely thought to be centered around
proper folding and quality control of proteins.2

1

With N-linked glycosylation being one of the most well understood forms of
glycosylation, other forms of glycosylation are generally thought to follow a similar pattern of
formation. O-linked glycosylation provides many different glycans that are directly attached to
proteins through a Ser/Thr residue; these include O-GlcNAc, O-GalNAc, O-glucose, and Oxylose. O-GlcNAcylation of proteins is catalyzed by the O-GlcNAc transferase (OGT) and the
donor substrate UDP-galactose within intracellular areas like the nucleus and cytoplasm. 3 OGalNAc is catalyzed by multiple different GalNAc transferases (GALNTs) that feature catalytic
domains in the Golgi lumen to attach GalNAc (donated by UDP-GalNAc) to Ser/Thr. 4 Protein
O-glucosyltransferase 1 (POGLUT1) adds both glucose and xylose to epidermal growth factorlike (EGF) repeats, and a deficiency in the enzyme results in muscular dystrophy in humans. 5
Another form of O-glycosylation adds to a different domain found across multiple proteins, like
protein O-fucosyltransferase 1 and 2 (POFUT1, POFUT2). POFUT2 adds the monosaccharide
fucose to thrombospondin type 1 repeats (TSRs) on Ser/Thr residues through an oxygen-carbon
bond. This modification is essential to human development; a lack of O-fucosylation on TSRs
results in the developmental disorder known as Peter’s Plus Syndrome. 6 Fucosylated residues
can also be elongated by other glycosyltransferases that are similarly important for healthy
human development. Beta-1,3-glucosyltransferase adds glucose on top of a fucosylated Ser/Thr
side chain, with further implications in the same developmental disorder for those lacking the
modification.7 Figure 1 shows the linkages of amino acid side chains in both N- and O- glycans.
All of these different protein modifications play roles in biological processes like protein
folding/quality control and stages of healthy human development. A third form of glycosylation,
C-mannosylation, has been implicated in the innate immune response through the upregulation
of secreted, cell-signaling proteins known as cytokines.
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Figure 1: Examples of O- and N-linked glycosylation. Adapted from Lehninger, A. L., Nelson, D. L. 1.,
& Cox, M. M. (2008). Lehninger Principles of Biochemistry (5th ed.). New York; New Delhi: W.H.
Freeman8

1.2 C-MANNOSYLATION
Both N- and O-linked glycosylation are implicated in important biological processes like
protein stability, folding, and healthy human development. These modifications occur on specific
amino acid side chains within consensus sequences. Like the two previously described
glycosylation types, C-mannosylation features its own distinct modification site. Cmannosylation is the direct addition of a mannose monosaccharide by a C-mannosyltransferase
3

expressed in the endoplasmic reticulum. As opposed to a reaction occurring on a more reactive
oxygen or nitrogen atom, the carbohydrate is added directly to the second carbon found on the
indole ring of a tryptophan, as shown in Figure 2. For this study, this type of glycosylation was
initially observed within the context of the thrombospondin type one repeat (TSR). TSRs feature
more than one consensus sequence; upstream of the O-mannosylation site is a series of
tryptophan residues. These are arranged as W-x-x-W-x-x-W/C, with ‘x’ denoting any other
amino acid. This consensus sequence is the site of C-mannosylation and is thought to be required
for the modification to occur.9 Figure 3 presents a TSR domain, with both sites of glycosylation
highlighted.
Within the consensus sequence, the mannose can be found on all three tryptophan
residues. No elongation occurs in this case of glycosylation; only the monosaccharide form has
been observed, and four human homologs of the transferase have been identified. 10 Cmannosylation has been implicated in a few different functions. A lack of C-mannosylation in
male sperm cells has been noted to result in the condition known as globozoospermia, an
abnormal development of male sperm that results in infertility.11 In another case, a lack of Cmannosylation on the protein ADAMTSL-1 saw a substantial increase in the intracellular levels
of the protein. ADAMTSL-1 is known to be a protein that proceeds through the secretion
pathway; this suggests that C-mannosylation is necessary for protein secretion.11 These two cases
underscore the importance of C-mannosylation in healthy cell development and secretory
pathways. C-mannosylation has been noted to occur in cell lines like chinese hamster ovary
(CHO) cells, and the murine RAW264.7 cell line.
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Figure 2: C-mannosylated tryptophan side chain. D-mannose is bound by a carbon to carbon on C2 of
tryptophan’s indole ring.

In murine macrophage-like cells (RAW264.7), expression of naturally C-mannosylated
proteins was discovered by immunoblotting techniques. An antibody was built against
synthetically mannosylated tryptophan (CMW) residues. Using this antibody with RAW264.7
cells, numerous protein bands were observed from immunostained cell lysates. Of the stained
bands, one such mannosylated protein was Thrombospondin-1 (TSP-1). This corresponded to
two of the most prominent bands observed by anti-CMW staining. 12
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Figure 3: Depiction of TSR with consensus sequences and glycosyltransferases. Provided with
consent by Dr. Robert S. Haltiwanger, University of Georgia.13

The identification of C-mannosylated proteins in RAW264.7 cells also showed that Cmannosylation was increased in hyperglycemic conditions. Noting these conditions as being able
to produce cellular change, more work was conducted on observing the effects of C-mannose as
an instigator of cellular response. RAW264.7 cells are typically used in immunology to studies
with a focus on the innate immune response. Using chemically-derived C-mannosylated
peptides, it was found that C-mannosylation upregulates the production of pro-inflammatory
cytokines. Also, this upregulation was further increased when RAW264.7 cells were cultured
with lipopolysaccharide infused media to simulate a bacterial infection, or in other words a
period of cell stress and response.14
A separate study focused on the potential for C-mannosylated peptides to interact with
other proteins that are in some way related to the innate immune response. When derived
peptides were endocytosed by RAW264.7 cells and isolated after lysing the cells, other proteins
were found to interact with the C-mannosylated peptide. Of these, Hsc70 was characterized by
6

blotting with anti-Hsc70 antibodies. This heat shock protein is an important molecular chaperone
that facilitates proper protein folding during times of cellular stress, and was theorized to be
important to the overall pro-inflammatory upregulation that LPS and C-Man-W were
influencing.15
This same study showed that introduction of exogenous C-mannosylated peptides and
Hsc70 to RAW264.7 cells could increase cytokine production. When paired together, the
specific upregulation of TNF-α is higher than cases observed when these are introduced to the
cells separately. Knowing that C-mannosylated peptides and Hsc70 can interact to cause an
inflammatory response, and that LPS can also upregulate cytokine production, drove this study
to focus on potential endogenous C-mannoyslated proteins in RAW264.7 cells.
1.3 DPY19
The gene encoding the primary C-mannosyltransferase was first detailed as an ER
localized enzyme in C. elegans.16 Dolichol-P-mannose is a known substrate for other Cmannosyltransferases like protein O-mannosyl transferases and oligosaccharyltransferases.17,18
The Bakker group used this knowledge of the sugar donor to begin their study of the transferase.
Using Drosophila cells, the group noted high levels of in vitro mannose transfer from
radiolabeled Dol-P-Man to synthetic peptides bearing the consensus sequence. Noting that this
activity was highest in ER-rich fractions of these cells, they concluded that this process occurred
in a manner similar to other glycosyltransferases.16
There are four human homologs to DPY19, namely DPY19L1, 2, 3, and 4. DPY19L1 and
L3 are known to C-mannosylate TSRs in mammalian cell lines, while DPY19L2 is important to
the development of human sperm.11,19 DPY19L4 is expressed in mammalian cell lines, but its
function is unknown.19 Though the enzyme shares homology with the other C-
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mannosyltransferases, it doesn’t exhibit C-mannosylation of TSRs. If the enzyme is indeed a Cmannosyltransferase, other targets or C-mannosylated tryptophans that are not part of the
canonical motif have yet to be identified.19
1.4 HSC70
Heat shock cognate 71 kDa protein (Hsc70), is a constitutively expressed member of the
larger Hsp70 family. As with other heat shock proteins, Hsc70 is a molecular chaperone; this
class of proteins is expressed to facilitate the folding of other proteins. In the case of heat shock
proteins, molecular chaperones facilitate protein folding during periods of intense cellular stress
that includes sudden levels of high heat exposure. The inflammatory response to a bacterial
infection causes a rapid increase in temperature that can halt protein expression in mouse cell
lines, whereas heat shock proteins like Hsc70 are consistently expressed to prevent damage to
other proteins.20
Previous studies have indicated that both Hsc70 and C-mannosylated peptides could be
influential to the innate immune response. In humans, Hsc70 features three different
substructures. These include an N-terminal ATPase domain, a peptide binding domain, and Cterminal domain.21 The substrate binding domain would be the most likely point of interaction
for a C-mannosylated protein and Hsc70. However, the manner in which this protein complex is
formed has yet to be elucidated.
1.5 INNATE IMMUNE RESPONSE AND LIPOPOLYSACCHARIDE
The innate immune response is described as the non-specific reaction by proteins and
cells to highly-conserved features of pathogens.22 In macrophages, cell surface receptors
recognize bacterial antigens to initiate the non-specific response. Lipopolysaccharide (LPS),
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found on the surface of gram-negative bacteria, is the initiator of the macrophage inflammatory
response to a bacterial infection.
Lipopolysaccharide is a component of the outer membrane of gram-negative bacteria.
This molecule consists of a lipid linked to a repeating O-glycan (O-antigen) by another core
glycan. This structure is recognized by the outer surface of the RAW264.7 cells via LPS-binding
protein (LBP). The protein transports LPS to CD14, a coreceptor to toll-like receptor 4 (TLR4).
TLR4 is an initiator of the innate immune response in macrophage cells, initiating a cascade of
signaling events and ultimately phosphorylating nuclear factor-kappa B (NF-κB), a transcription
factor that is incorporated in the nucleus once its subunits are phosphorylated. 22 This factor
regulates the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) at the transcription
level.23 This cytokine is responsible for inflammatory signal transduction that eventually leads to
cellular apoptosis and necrosis.25 Figure 4 illustrates the signal transduction in the context of
human monocytes, yet this pathway is conserved in the RAW264.7 cell line.
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Figure 4: Innate immunity pathways initiated by lipopolysaccharide. Adapted from Guha, M., &
Mackman, N. (2001). LPS induction of gene expression in human monocytes. Cellular signaling, 13(2),
85-94.24

Previous studies have indicated that Hsc70 and a C-mannosylated peptide may prove
instrumental in the regulation of TNF-α expression in RAW264.7 cells, and could expand to
human immune cells. Exploring the relationship between Hsc70 and its potential binding
candidates could elucidate such a role for C-mannosylated candidates.
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CHAPTER 2
METHODS
2.1 MAMMALIAN TISSUE CULTURE
RAW264.7 macrophage-like cells were the model system for this study. To simulate a
bacterial infection to activate the macrophages, the cells were grown in culture media both with
and without LPS. The LPS-treated media consisted of Dulbecco’s Modified Eagle Medium
(DMEM), 10% fetal bovine serum to supply vital growth nutrients, and penicillin/streptomycin
to prevent bacterial infections. LPS-treated cells were serum-depleted 24 h prior to LPS
stimulation. LPS was added at a concentration of 1 µg/mL as cell viability was previously
determined to be greatest at this concentration.26 Control cells received media without added
LPS.
Timepoints of the RAW264.7 cells were collected throughout the study. Cells were
collected at 0, 2, 4, 12, 24, and 48-h post-LPS stimulation. Stimulated cells were grown to
roughly 70% confluence in either 10 cm2 culture dishes in triplicate with non-LPS infused
media, or in single 175 cm2 flasks. Once a plate/flask reached this confluence level, the non-LPS
media was aspirated from the container and replaced with LPS infused media, and the time point
began from there. For example, a 0-h flask would have been collected immediately after LPS
media was added, and a 12-h flask would have been collected 12 h after the media was added.
Control cells were given fresh non-LPS media at the same time the LPS infused counterparts’
media was swapped, then collected in parallel.
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2.2 CO-IMMUNOPRECIPITATION

Figure 5: Hsc70 co-immunoprecipitation strategy
A) Schematic for Hsc70 co-immunoprecipitation. B) Top panel: separation of Hsc70 and IgG primary
antibody via SDS-PAGE. Bottom panel: Hsc70 identification via western blot.

To isolate Hsc70 from RAW264.7 cells and characterize any interacting proteins, a coimmunoprecipitation strategy was utilized. A primary anti-Hsc70 antibody was incubated with
magnetic beads conjugated to Protein G. The Protein G beads gave the antibody a stable, solid
support to easily isolate the protein complex. Figure 5 illustrates the binding schematic and
preliminary results.
Noting that Hsc70 has been shown to interact and co-precipitate chemically derived Cmannosylated peptides, this strategy aimed to isolate Hsc70 and any other interacting protein.
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The bead-antibody complex was incubated with crude RAW264.7 cell lysates to isolate Hsc70.
Washing the complex with phosphate buffered saline (PBS) removed any proteins not
interacting with Hsc70; applying heat eluted the Hsc70 protein complex from the antibody to
visualize it via SDS-PAGE. Figure 5 also illustrates this in panel B.
2.3 SDS-PAGE
Hsc70 has a known molecular weight of 70 kDa. The easiest way to identify this protein
is thus to identify it by its weight. Electrophoresis was utilized heavily in this study to separate
and characterize proteins based on their molecular weight. Various forms of electrophoresis
allow for quick visualization of the large number of proteins in RAW264.7 cell lysates, as well
as those present in immunoprecipitations and IP washes. The specific method of SDS-PAGE was
utilized to separate proteins based solely on their weight without having to account for other
features of proteins that could be part of the Hsc70 complex.
Pre-cast and poured BioRad minigels were utilized in SDS-PAGE experiments. Pre-cast
gels and polyacrylamide were purchased from Bio-Rad (Hercules, CA, United States). These
gels featured a 12% continuous layer of polyacrylamide to allow for uniform pore sizes,
separating proteins based on their migration time across the gel. Larger proteins moved slowly
towards the cathode, while smaller proteins moved more quickly. In the continuous gels, the
polyacrylamide gel featured a stacking and resolving layer. The stacking layer allowed for
proteins to migrate at the same pace and ‘stack’ into a single band. The second layer, or
resolving layer, featured medium-sized pores based on the 12% polyacrylamide concentration in
that layer. A higher percentage of polyacrylamide correlated with smaller pores, and lower
percentages had larger pores. For poured gels, TEMED and ammonium persulfate from Thermo
Fisher Scientific (Waltham, MA, United States) were used to promote polymerization of
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acrylamide to form a gel matrix. Thermo Fisher SureCast Stacking (0.5 M Tris-HCl, pH 6.8) and
Resolving (1.5 M Tris, pH 8.8) buffers were used alongside ammonium persulfate and TEMED
to make the two gel layers. Gradient gels were also used, where gels had pores that decreased in
size as proteins moved down the gel. The gradient gels eliminated the need for a stacking gel, as
the changes in pore size prevented proteins of larger sizes from migrating past a certain point on
the gel.
SDS-PAGE allowed for the migration of proteins based solely on their molecular weight
due to the application of sodium dodecyl sulfate (SDS). A protein sample (crude cell lysate,
immunoprecipitation elution, washes, etc.) was first reduced in a buffer containing betamercaptoethanol. Reducing buffers reduced disulfide bridges to unfold protein tertiary structure
and provide a “linear” form of the proteins in the sample. The addition of SDS, a detergent,
further unfolds proteins into a linear form.27 The SDS molecule also conferred a negative charge
to the proteins. Reduced protein samples were loaded into the top of an SDS-PAGE gel, where
the anode is located. As an electric potential was applied to the gel, proteins migrated toward the
cathode located at the bottom of the gel, being filtered by the porous resolving layer as they
moved further down.27
To visualize the proteins trapped in the gel pores, two different staining methods were
utilized. Typically, Coomassie blue staining was used to stain the gel. This stain binds to the
trapped proteins, but doesn’t bind as well to the gel components, meaning that it could easily be
washed off using an acidic destaining solution. The manufacturer BioRad lists the sensitivity for
this stain as between 30 – 50 ng of protein. However, sometimes even less protein was trapped in
the gel pores, and still proved relevant to the study. To visualize such small concentrations of
protein, silver staining was utilized. The Pierce Silver Stain for Mass Spectrometry kit, again
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from Thermo Fisher, advertised a sensitivity for protein concentrations less than 0.25 ng, making
it over a hundred times more sensitive than the Coomassie method. Similar to the Coomassie
method, silver deposits bound the peptides to clearly visualize them. A destaining solution
contained in the kit removed silver deposits so that peptides could be further characterized by
mass spectrometry.
2.4 WESTERN BLOTTING
While gel electrophoresis allowed for detection of proteins based solely on mass, it did
not reveal much information on the specific protein primary structure. Western blotting allowed
for more specific identification of proteins isolated by gel electrophoresis using antibodies
generated in host animals against the specific proteins of interest in this study. A common target
of western blotting was Hsc70, allowing for proteins not detected by an Hsc70 antibody to be
further examined as potential candidates in a C-mannosylated protein-Hsc70 complex.
Beginning with an SDS-PAGE gel, isolated proteins were transferred to a nitrocellulose
membrane to allow for detection of proteins with a primary antibody. Nitrocellulose membranes
feature a higher affinity for proteins than a gel; the porous nature of a gel would also present the
issue of proteins diffusing through the gel matrix over time. Immobilizing the proteins on a
membrane makes detection via antibodies possible. The primary antibodies were grown in a host
animal different from the cell type that the proteins were isolated from. In this case, antibodies
generated in hosts like goats and rabbits were selected as primary antibodies to avoid crossreactivity with endogenous proteins from the same type of animal. Immunoglobin G antibodies
(IgG) were the most common type of antibody used in this study.
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Figure 6: Secondary detection of IgG antibody via horse radish peroxidase-conjugated antibodies.

The IgG structure featured two heavy and two light chains; the heavy chains are linked
together by disulfide bonds and linked to the separate light chains by separate disulfide bonds.
The N-terminus featured the variable region where two antigen binding sites are located; this is
where the primary antibody recognizes and binds to the antigen. The C-terminus featured a
constant region, where the amino acids of the heavy chains are conserved across the IgG type.
The constant region is where secondary detection of the primary antibody by an anti-IgG
secondary antibody occurred.28
The choice of the secondary antibody was again determined by host reactivity and
immunoglobin type. The variable region of the secondary antibody recognized the constant
region of the primary. These goat/rabbit-generated secondary antibodies can recognize any IgG16

type antibody due to the conserved amino acid sequence across all IgG constant regions. To
detect the secondary/primary antibody construct, two methods were used. Some secondary
antibodies were conjugated with horseradish peroxidase (HRP), an enzyme that catalyzes the
oxidation of a substrate to produce light. Luminol was frequently used as an HRP substrate, and
its oxidation by peroxide causes a strong emission of light; this process is known as
chemiluminescence, and allowed for visualization of the protein of interest by indicating where
chemiluminescence occurred on the blotting membrane, as illustrated in figure 6. Other
secondary antibodies were conjugated with IRDye, a product from LI-COR Biosciences
(Lincoln, NE, United States). Instead of using an enzyme to catalyze a light-producing reaction,
the IRDye simply absorbed light at one wavelength, then produced light of a particular
wavelength. Using the LI-COR Odyssey imaging system, multiple blots were visualized with
IRDye antibodies.29
2.5 MASS SPECTROMETRY SAMPLE PREPARATION
Preparation of SDS-PAGE samples for mass spectrometry is an essential process to
acquire accurate data. Bands from the SDS-PAGE gel were physically excised using a razor
blade and kept in microcentrifuge tubes. The bands in these gels contained proteins that were
then reduced through the use of tris(2-carboxyethyl)phosphine (TCEP); this breaks disulfide
bonds that maintain the tertiary structure of the protein. Dithiothreitol (DTT) was also used for
this purpose. For preparation for the Orbitrap instrument, 100 µL of “reduction solution” (4 µL
TCEP from 0.5 M stock and 96 µL 50 mM Tris-HCl pH 6.8) were added to excised gel pieces.
Iodoacetamide is then used to alkylate the sulfhydryl (-S-H) groups in order to prevent
reformation of the disulfide bonds.30
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With the proteins alkylated, an enzymatic digestion by proteases such as trypsin and
chymotrypsin was performed. Trypsin cleaved c-terminal to basic residues like lysine and
arginine, whereas chymotrypsin cleaved after aromatic residues like tyrosine, phenylalanine, and
tryptophan. Trypsin and chymotrypsin are both categorized as serine proteases; these enzymes
utilized a serine sidechain within their active sites to perform a nucleophilic attack on the peptide
bond which is cleaved.
Preparation of samples for MALDI-TOF characterization required some specific protocol
changes. DTT reductions occurred in 25 mM NH4C2H3O2 at 56 °C for 1 h; 1.5 mg of DTT was
dissolved in 1 mL 25 mM NH4C2H3O2, with 25 µL of the resulting solution added to each
excised gel piece. Iodoacetamide alkylations utilized 25 µL of 55 mM iodoacetamide added to
reduced samples. Gel pieces were then dehydrated with 25 mM NH 4HCO3 in 50% acetonitrile
prior to tryptic digests, which was performed in 25 mM NH 4C2H3O2.
Following the enzymatic cleavages, peptides were extracted for analysis with a C18
ZipTip. The pipet tip is packed with a nonpolar, hydrophobic alkyl chain to do reverse-phase
chromatography within the tip. The nonpolar stationary phase allowed for the weakly polar
peptides to be trapped in the tip when extracted from solution. The tip was washed to eliminate
any salts that would interfere with the ionization process; peptides were then eluted from the
column using acetonitrile due to its high relative polarity. For the MALDI-TOF analysis, peptide
solutions were mixed with matrix and spotted onto the sample plate. For the hybrid orbitrapquadrupole analysis, the eluted peptide solutions were diluted to proper levels of acetonitrile
concentration prior to injection onto a C18 column for HPLC separation.31
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2.6 MATRIX ASSISTED LASER DESORPTION/IONIZATION – TIME OF FLIGHT
(MALDI-TOF)
Western blot technologies essentially gave a positive/negative response as to whether a
protein was expressed in a cell line. To know what specific protein was detected, mass
spectrometry was necessary to identify proteins by the mass fingerprint technique. Mass
spectrometry is an analytical technique in which ions are detected and masses determined. To
accomplish this, ions are detected based on their relative kinetic energy when reaching a mass
detector. The mass analyzer separates the peptide ions by their m/z values, their mass to charge
ratio. The first type of mass spectrometry used in this study was matrix-assisted laser desorption
ionization time-of-flight, or MALDI-TOF.
MALDI-TOF is a useful type of MS for analyzing biomolecules. Many other types of MS
require volatile molecules that readily go into the gas phase; proteins are nonvolatile and require
assistance to reach this phase. Applying enough heat to cause a protein to reach this phase would
ultimately destroy or decompose the protein before a mass to charge ratio could be obtained. To
assist a biomolecule in entering the gas phase, a crystalline matrix (organic acids with ring
structures) is mixed with the biomolecule (analyte). The matrix absorbed photons from a high
intensity N2 laser, causing the matrix/analyte molecules to be desorbed into the gas phase at the
same time. The matrix molecule transfers a proton to a basic group (like R, K, and N-terminus)
in the peptide; the matrix α-cyano-4-hydroxycinnamic acid produced uniform (M+H) + peptide
ions due to its acidity relative to the analyte. The peptide ions were accelerated into a flight tube,
where each ion has the same kinetic energy based on the voltage on the accelerating lens. The
time it takes an ion to reach a detector while passing through a flight tube is proportional to the
mass-to-charge ratio. An equation for kinetic energy presents this information:
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𝐸=

1
𝑚𝑣
2

Kinetic energy is equal to the charge of an ion and the accelerating lens voltage, which
rearranges the equation.
∗

𝑣=
Factoring in the time delay (t) for the ions to reach the detector through a flight tube depends on
the drift region found within the tube (L).
𝑡=

√

∗

∗

The above equation gives the mass-to-charge (m/z) ratio as a function of time with respect to the
path length and voltage (V) of the instrument.
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2.7 ESI-LC MS ORBITRAP – Q EXACTIVE HYBRID QUADRUPOLE-ORBITRAP
Electrospray ionization (ESI) is also used to get nonvolatile biomolecules in the gas
phase. ESI is considered a “soft” ionization technique in that it does not fragment the peptide
into numerous smaller particles. The eluted peptide solution was passed through a charged
nozzle at a high pressure to generate charged droplets. The solvent then transferred protons to the
peptides to generate a range of ion species. Drying gases like nitrogen continually remove
solvent around the now charged peptides; as the solvent volume was reduced, ions would be
forced into smaller and smaller ion packets. The drying continued until only single ions were left
in the gas phase. Unlike MALDI-TOF, where a vacuum co-crystalizes both the matrix and
analyte, this method is purely solution based with no intermediate solid phase. 32
The ion species sprayed from the ESI tip then travels to a quadrupole precursor ion
selector, the first part of the tandem mass spectrometer. The quadrupole-filtered ions based on
their m/z ratio by alternating radio frequencies. The quadrupole caused the ions to oscillate
between the charged poles, where ions of a certain mass are spun out of the quadrupole; ions that
filter through are then transferred to an HCD trap for fragmentation, which is later presented as
MS/MS data by the mass analyzer located in the orbitrap. Fragmented ions were then released
back to the curved linear trap.
The curved linear trap (C-trap) used a collision gas (nitrogen) to reduce the kinetic energy
of ions that have been fragmented within the HCD trap. From the C-trap, reduced-energy ions
were sent to the orbitrap for detection and analysis. The detection of the m/z values of the
fragment ions was based on their characteristic oscillation frequencies as observed in the
orbitrap.31
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CHAPTER 3
HSC70, JUNCTOPHILIN-1, AND HEK293T TRANSFECTIONS
3.1 HSC70 CO-IMMUNOPRECIPITATION

Figure 7: Silver stained SDS-PAGE gel of immunoprecipitated RAW264.7 lysates.
-LPS indicates non-stimulated samples, while +LPS indicates cells grown in LPS infused media. Red
asterisks indicate protein bands roughly corresponding to 70 kDa when compared to the protein standard.

The outlined Hsc70 co-immunoprecipitation was performed across many different
timepoints across the RAW264.7 cells. Hsc70 was precipitated from RAW cells with LPS
infused media at 2 and 24 h post stimulation, and at 0, 2, 24, and 48 h without LPS. As Figure 7
shows, numerous protein bands were visible alongside Hsc70 once the co-immunoprecipitations
were visualized via silver-staining. As predicted with the co-immunoprecipitation strategy, any
one of these bands were noted as potentially interacting proteins within an Hsc70-Cmannosylated protein complex. Each band in Figure 7 not identified as Hsc70 was excised from
the gel and prepared for identification via mass-spectrometry.
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Figure 8: MS/MS spectra and extracted ion chromatogram of C-mannosylated JPH1 peptide. A)
MS/MS collision induced dissociation spectra of JPH1 peptide. B) Extracted ion chromatogram of JPH1
peptide.

Many proteins were identified alongside Hsc70 from these co-immunoprecipitations.
Among these was Junctophilin-1 (JPH1), a protein typically found in skeletal muscle. A single
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peptide bearing a hexose on a tryptophan residue was identified. Curiously, this peptide did not
bear the W-x-x-W-x-x-W/C consensus sequence. Building an extracted ion chromatogram for
the C-mannosylated peptide showed an almost 100% relative abundance of the modified peptide
compared to an unmodified, or “naked” peptide, shown in Figure 8 alongside its relevant
MS/MS spectra. When researching the full primary sequence for JPH1, it was also noted that this
protein did not contain a single TSR. To confirm the status of JPH1 as a putatively Cmannosylated protein, attention was turned to focus on overexpression of the protein in a cell
line that would readily express the protein.
3.2 TRANSIENT JPH-1 TRANSFECTION - POLYETHYLENIMINE
A pCMV6 entry vector containing JPH1 (OriGene, Rockville, MD) was used to
transiently transfect the full-length protein into HEK293T cells, a human embryonic kidney cell
line used for their particularly robust ability to express transfected proteins. HEK293T cells were
seeded at 850,000 cells per well in a 6-well culture plate. These cells were diluted in DMEM +
10% bovine calf serum, with no antibiotics present in the media. Cells were incubated overnight
at 37 ºC and 5% CO2. Afterward, a transfection mix containing 1.6 µg of JPH1 plasmid, 0.1 µg
of human IgG construct as a positive transfection control, and 30.6 µL polyethylenimine (PEI) to
facilitate the transfection. PEI condensed the plasmid into small charged particles to interact with
the negatively charged surface of the HEK cells; the plasmid was subsequently endocytosed into
the cell, where the cDNA was used to express the protein. A control master mix was also made
in triplicate with pSec2Tag2 empty vector used in place of the JPH1 plasmid. Both master mixes
were diluted in OPTI-MEM, a low-glucose growth medium.
Respective master mixes were added dropwise to the HEK293T growth media. Cells
were incubated at 37 ºC and 5% CO2 for 4 hours. After the incubation, the media was aspirated
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from the cells, and the cells were washed with warm 1x PBS. Following the wash, 700 µL of
OPTI-MEM was added to each well of cells and the plate was returned to the incubator. Cells
were harvested and lysed roughly 48 hours post-transfection.
3.3 WESTERN-BLOT: CO-TRANSFECTED JPH1
Following the collection of transfected HEK293T cell lysates, crude lysates were boiled
in a reducing buffer and run on a precast SDS-PAGE minigel. Protein bands trapped in the gel
were transferred to a nitrocellulose membrane, and then blotted with an anti-Myc antibody at
1:1000 dilution in a 5% w/v buffer of powdered milk and TBS-T. The JPH1 vector also
contained a coding region for a c-Myc tag and FLAG, two protein tags that were used as
commonly recognizable antigens for primary antibodies. Secondary antibodies, goat anti-mouse
and goat anti-human, were used at a dilution of 1:10,000 in the same buffer, binding the primary
anti-myc antibody and human IgG construct respectively.

Figure 9: Western blot of JPH1-IgG co-transfected HEK293T cell lysates. Myc+ refers to myctagged ADAMTSL2 standard, EV refers to cells transfected with pSec empty vector, and JPH-1 refers to
cells transfected with JPH-1 plasmid. All cells were transfected with a human IgG construct.
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As expected, the primary anti-Myc antibody only bound the protein tag in the transfected
crude cell lysates. Cells transfected with empty vector and hIgG showed no bands corresponding
with c-Myc-tagged proteins. Figure 9 shows this western blot, where the presence of Myctagged proteins was confirmed. To further confirm that the Myc-tagged bands were transfected
Junctophilin-1, the same crude cell lysates were separated through another SDS-PAGE gel to be
processed for mass spectrometry.

Figure 10: CBB stained SDS-PAGE gel of transfected HEK293T crude cell lysates and bovine
serum albumin. Lysates are included in the leftmost lane and decreasing concentrations of BSA standard
are included in the BSA labeled lanes. MW indicates the molecular weight standard.

Cell lysates were used in one lane, while bovine serum albumin (BSA) was used as a
control to roughly estimate the concentration of protein observed in the lysate. As seen from the
gel in Figure 10, the lysates far exceeded 2 µg of protein, so much so that the protein band of
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interest was obfuscated. Comparing the gel to the previous western blot, a part of the lysate lane
corresponding to roughly 75 kDa was excised from the gel to be reduced, alkylated, and cleaved
with trypsin to be prepared for the mass spectrometer.
3.4 HYBRID QUADRUPOLE-ORBITRAP MS/MS

Figure 11: MS/MS spectrum of JPH1 peptide. Spectrum was taken from Byonic analysis software,
with m/z ratio plotted on the x-axis and peak intensity plotted on the y-axis.

After the transfected proteins were proteolytically cleaved and injected into the mass
spectrometer, tandem mass spectra were generated. The MS/MS data presented in Figure 11
shows that a peptide nearly identical to the original endogenous JPH1 example was isolated from
the transfected cells. Since only trypsin was used in this digest, an extra tyrosine was included on
the peptide. When compared to the UniProt mouse protein database, this peptide was found to be
unmodified in HEK293T cells. Other peptides featuring tryptophan were also identified by
collision induced dissociation of peptides injected into the instrument. No TSR modules were
noted in either peptide or motifs for C-mannosylation. A modified peptide different from the two
presented here was detected by Byonic MS analysis software, but with a “low confidence”
rating. The low confidence rating indicated that few ions were detected, and the peptide was
constructed based on predictions made by the software.
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Figure 12: MS/MS spectrum of JPH1 peptide. Spectrum was taken from Byonic analysis software,
with m/z ratio plotted on the x-axis and peak intensity plotted on the y-axis.

While JPH1 was successfully transfected into HEK293T cells, no C-mannosylated
peptides were detected by the Orbitrap mass analyzer. Figure 12 presents a second JPH1 peptide
from the previously displayed gel, but this was also unmodified. As described previously, Cmannosylation has been found to occur in RAW264.7 cells to multiple proteins with the
necessary consensus sequence. However, no data has been shown for this to be a naturally
occurring process in HEK293T cells. With this knowledge, focus was turned back to the
RAW264.7 system. Using multiple transfection methods, attempts were made to overexpress
JPH1 in the cell line.
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CHAPTER 4
RAW264.7 TRANSFECTIONS AND ENDOGENOUS IMMUNOPRECIPITATIONS
4.1 ELECTROPORATION OF RAW264.7 CELLS

Figure 13: Western blots of electroporated RAW264.7 cells.
120V and 150V refer to potential difference settings at which cells underwent electroporation.

RAW264.7 cells proved to be difficult to transfect with plasmid DNA through
conventional PEI based methods. One of the attempted methods at incorporating plasmid DNA
in the cell line was electroporation. Cells were grown to a density of roughly 190,000 cells/mL,
then placed in a cuvette along with roughly 18 µg JPH1 DNA. A brief pulse of electricity was
passed through leads on opposite sides of the cuvette to open pores in the cell membrane,
allowing the DNA to pass into the cytosol of the RAW264.7 cells.
Following the electroporation, cells were taken from the cuvette and resuspended in fresh
DMEM growth media, then allowed to grow on a 10 cm. 2 plate. Cells were harvested once they
had reached roughly 70% confluency, lysed, and subjected to the typical western blot protocol.
Crude cell lysates that underwent electroporation at 120 and 150 V were blotted against using
anti-Myc and IgG antibodies. No proteins were detected by the anti-Myc antibody, but some
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bands appeared that corresponded with the IgG construct that was co-transfected with JPH1
DNA, as seen in Figure 13.
4.2 TRANSFECTION – LIPOFECTAMINE 2000 AND LTX

Figure 14: JPH1 immunoprecipitation and western blot Western blot of JPH1 transfected RAW264.7
cells that were also immunoprecipitated with an anti-JPH-1 antibody. MW indicates the molecular weight
standard, with two chemiluminescent standard peptides. Lys is crude cellular lysate, O/N is the solution
flowthrough after overnight immunoprecipitation. Washes 1-3 are indicated by W1, W2, W3, and eluted
samples are included in the Elut lane. Primary antibody was used at 2 µg/mL buffer, secondary at
1:10,000 dilution.

Successive attempts at transfection of JPH1 into RAW264.7 cells using PEI proved to be
unsuccessful. Lipofectamine is a class of reagents that form lipid-DNA complexes to facilitate
transfections into mammalian cells by less stressful means. DNA is encased by a cationic
liposome to overcome the repulsion between the plasmid and cell membrane, both of which are
negatively charged. Two different Lipofectamine reagents were used, 2000 and LTX.
Lipofectamine LTX is marketed as a reagent with a specific protocol outlined for RAW264.7
DNA transfections. Based on multiple western blots, Lipofectamine 2000 did not produce any
viable JPH1 transfections for RAW264.7 cells. Lipofectamine LTX produced one western blot
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that appeared to be a positive result for an anti-JPH1 blot of RAW264.7 cells that appeared to
have been successfully transfected, as seen in Figure 14. Unfortunately, MALDI-TOF mass
spectrometry of these protein bands did not return any results for JPH-1 peptides.
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4.3 MALDI-TOF SPECTRA OF DIGESTED RAW264.7 PROTEINS
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Figure 15: MALDI-TOF MS spectrum of JPH1 transfected RAW264.7 cells. X-axis represents m/z
values, while y-axis represents relative intensity.

Further attempts at transfection of mouse JPH-1 into RAW264.7 cells were attempted
after returning to Marshall University. Various concentrations of JPH-1 plasmid and
lipofectamine reagents were used to facilitate the transfection. Crude cell lysates and
immunoprecipitations of attempted RAW264.7 cell transfections were measured by Dr. Frost of
the Marshall University Department of Chemistry to be characterized by MALDI-TOF mass
spectrometry. Following the previously outlined mass spectrometry processing techniques,
peptides were enzymatically digested for characterization via MALDI-TOF. Figure 14 shows
multiple peaks across a MS spectrum that correspond with the weight of various peptides.
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However, these peaks did not correspond to previously identified peptides from JPH1, including
the C-mannosylated peptide identified from the Hsc70 co-immunoprecipitation. Based on
peptide fingerprinting and Mascot peptide database comparisons, 1110 m/z would correspond
with the peptide YEGEWANNK, while 946 m/z would be EGEWANNK.
4.4 RyR1 IMMUNOPRECIPITATION
Facing difficulties with JPH1 transfections and immunoprecipitations, a new target for
co-immunoprecipitation was chosen. The Ryanodine receptor type 1 (RyR1) is a protein that
mediates the release of calcium ions stored within the sarcoplasmic reticulum, found within
skeletal muscle. Using an anti-RyR antibody, an immunoprecipitation for endogenous RyR1 was
performed, with the aim to co-precipitate JPH1 as part of an RyR1-JPH1 complex. Figure 15
presents the RyR1 immunoprecipitation separated by and SDS-PAGE gel in the left panel, while
the right panel presents a western blot of the same samples using an anti-JPH1 antibody.

Figure 16: RyR1 immunoprecipitation and JPH1 western blot
Left panel: silver-stained SDS-PAGE gel of RyR1 IP from wildtype RAW264.7 cells. ‘W’ lanes indicate
washes, ‘Elut’ indicates eluted proteins, and ‘FT’ indicates the overnight flowthrough solution. Right
panel: anti-JPH1 western blot of RyR1-immunoprecipitated samples.
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While the western blot in the right panel presents many positive instances of protein
binding, these appear to have been false positives. Excising/digesting bands consistent across the
SDS-PAGE gel and the western blot, no proteins were found to match JPH1. RyR1 is a large
protein (over 250,000 Dalton) and could have aggregated at the top of the gel’s stacking layer,
preventing the RyR1-JPH1 complex from being separated by the gel. As for the false positives,
the anti-JPH1 antibody could have recognized an epitope common between the JPH1 target and
another non-specific protein.
4.5 JUNCTOPHILIN 1
Junctophilin 1 (JPH1) is a protein that features multiple integral membrane domains and
is essential to the function of excitable cell types like muscle and neuronal cells. This protein is
part of a larger family of proteins referred to as junctional membrane complex-associated
proteins (JMC). The structure of JPH1 contains several amino terminal membrane occupation
and recognition nexus (MORN) motifs; a motif of YxGxWxxGxRHGYG is conserved across
JPH isoforms. These motifs constitute two different MORN domains that anchor the protein into
the membrane of the ER, the organelle where C-mannosylation occurs.33, 34 The initially
identified C-mannosylated peptide featured a modification on W307 in its primary sequence.
This would place the modification on MORN motif VII, the last MORN motif and one of the
many domains that interact with the plasma membrane, as presented in Figure 17.

Figure 17: Junctophilin-1 diagram displaying MORN domains and connection to L-Type Calcium
Ion Channels. Adapted from Landstrom, A.P. et al (2014).35
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JPH1 is currently thought to function as a regulator for L-type Ca2+ channels (LTCC)
through RyR1. These channels are essential to the initiation of skeletal muscle contraction. A
joining region between MORN domains I and II interacts with the LTCC; JPH1 has also been
shown to interact with RyR1 expressed in skeletal muscle via disulfide bonds, which figure 18
presents. RyR1 is a mediator in the process of Ca2+ release from the sarcoplasmic reticulum (SR),
the skeletal muscle equivalent of the ER. RyR1 and LTCC have been shown to colocalize in
skeletal myoblasts in vitro; this colocalization is disrupted when JPH1 expression is silenced. 36, 37
All of this evidence points towards all three proteins operating in tandem with one another in the
ER, but doesn’t implicate them in the innate immune response.

Figure 18: JPH1 and RyR1 interaction via disulfide bonds in skeletal muscle cells. Adapted from
Landstrom, A.P. et al (2014).35
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4.6 CONCLUSIONS
Hsc70 is usable as a powerful proteomics tool based on its easy-to-precipitate nature that
has been demonstrated by this co-immunoprecipitation strategy. As a molecular chaperone
protein, Hsc70 interacts with numerous proteins during the innate immune response to facilitate
proper folding during a time of stress for all proteins. Being a constitutively expressed protein,
Hsc70 is a prime target for co-immunoprecipitation even if the macrophage cell line hasn’t been
activated by LPS.
As for its utility as a tool for glycoproteomics, Hsc70 is still a viable option even if its
full capabilities of isolating C-mannosylated proteins has yet to be discovered. This study has
indicated at least two different proteins that were previously unknown to be C-mannosylated,
with one of them being a non-canonical example of the modification. Currently, of the four
DPY19 homologs believed to C-mannosylate proteins, the function of DPY19L4 is currently
unknown. In knockout CHO cells, no difference in TSR C-mannosylation was noted when
DPY19L4 was expressed or silenced.
Other work in the Rakus lab conducted by Karli Boober (unpublished) utilized RTPCR
using RNA from both RAW264.7 and HEK293T cells. Junctophilin-1 was observed to be Cmannosylated on a specific peptide in RAW cells, but not HEK cells. Noting that DPY19L4
doesn’t C-mannosylate TSRs, it was hypothesized that HEK cells did not express DPY19L4 and
that perhaps RAW cells expressed this enzyme to C-mannosylate proteins that did not feature the
canonical C-mannosylation sequence. However, Ms. Boober’s data showed the opposite, with
HEK293T cells expressing all four homologs.
Again, while only a handful of endogenous examples of C-mannosylated proteins were
identified by a co-immunoprecipitation with Hsc70, this does not rule out its potential as a tool
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for identifying modified proteins. The co-immunoprecipitation presented here has expanded our
knowledge on C-mannosylation in that another as yet to be identified enzyme may be responsible
for C-mannosylation in RAW264.7 cells. These non-canonical examples of C-mannosylation
may also influence the innate immune response; deriving peptides like those identified in
Junctophilin-1 and artificially C-mannosylating tryptophan side chains would provide peptides
similar to those used in previous literature. Successfully permeabilizing the RAW cells would
allow for these peptides to enter the cytosol. Downstream assays of TNFα production postintroduction of artificially modified peptides would provide evidence of their role in septic levels
of pro-inflammatory cytokine production.
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